Fig. 1From: A positron emission tomography imaging study to confirm target engagement in the lungs of patients with idiopathic pulmonary fibrosis following a single dose of a novel inhaled αvβ6 integrin inhibitorStudy schematic for cohort 1. HRCT: high-resolution computed tomography; PET: positron emission tomography; PK: pharmacokinetics; PET1: PET scan on day 1 at ~30 min post-dose; PET2: PET scan on day 2 at ~24 h post-doseBack to article page